IgE-mediated asthma: New revelations and future insights Ratko Djukanovic (Southampton, United Kingdom), William Busse (Madison, United States of America), Nicola Hanania (Houston, United States of America), David Price (Aberdeen, United Kingdom)
| |
From clinical trials to real-world data: New dimensions of patient benefits Nicola Hanania (Houston, United States of America)
| |
Targeting IgE: New revelations, new concepts William Busse (Madison, United States of America)
| |
Which patient, what assessment and by whom? David Price (Aberdeen, United Kingdom)
| |
Focusing on your crucial questions Ratko Djukanovic (Southampton, United Kingdom), William Busse (Madison, United States of America), Nicola Hanania (Houston, United States of America), David Price (Aberdeen, United Kingdom)
| |
Future insights: IgE in 2025? Ratko Djukanovic (Southampton, United Kingdom)
| |